Technology

BioLeap > Technology > Media

Media

BioLeap’s platform consists of two technologies:

  • Monte Carlo simulation technology that creates target-specific fragment affinity binding data.
  • 3D design tools that guide the BioLeap chemists in designing novel compounds.

In these videos, Ian Cloudsdale, Ph.D., BioLeap’s Vice President of Chemistry, demonstrates how he uses the data and tools in the BioLeap design process.

Introduction to BioLeap’s Design Tools
In this video, isolated protein / small molecule molecular interactions are simulated.
(5 minutes)
View in separate window | View in fixed window

Constrained Fragment Analysis (CFA)
This video demonstrates the value of CFA in ligand design.
(7 minutes)
View in separate window | View in fixed window

CFA for De Novo Design
In this video, CFA is used to confirm that the ligand designs will fit in the active site. Changes in comparative ranking are discussed.
(11 minutes)
View in separate window | View in fixed window


Misc Media: A BioLeap Overview

BioLeap Overview
An Overview of BioLeap with David Pompliano, CEO
View in separate window | View in fixed window